Aptiv Q2 2026: Subpar Growth and Margin Challenge New Aptiv’s Re-Rating Thesis

What happened

Aptiv reported second-quarter 2026 revenue of $3.3 billion, up just 2% on an adjusted basis, with adjusted EBITDA of $613 million and net income of $298 million. This marks the first full quarter following the EDS spin-off, but the 2% organic expansion falls well short of the 4–5% annual growth underpinning the base-case investment thesis. The 18.6% adjusted EBITDA margin likewise misses the ~19% level that was central to the bull case for a re-rating toward $90. While management frames the results as sequential progress, the figures suggest that tariff and volume headwinds are still outweighing content gains and non-auto diversification. One quarter does not break the long-term story, but it sharpens the need for a convincing rebound in the second half to justify current valuation and sustain conviction in the New Aptiv growth algorithm.

Implication

Aptiv’s 2% revenue growth and 18.6% EBITDA margin signal a slow start for the newly independent entity, directly challenging the thesis that post-spin New Aptiv would immediately deliver 4–5% growth and expanding margins. With the spin completed, the market will judge the company solely on its ability to convert booked programs into above-market revenue and to offset auto cycle weakness with non-auto and software expansion. The miss increases the risk that the stock could drift toward the bear-case $65 if H2 does not show a clear acceleration, while the bull case above $100 recedes without at least 19.5% margins and 4%+ growth by year-end. Investors should monitor quarterly organic growth and margin progression closely, and position sizing should remain conservative until evidence of traction emerges. The re-assessment window now shortens from 6–12 months to 3–6 months, with a preference to wait for confirming data before adding exposure.

Thesis delta

The Q2 2026 results undershoot the base-case assumptions of ≥4% revenue growth and ≥19.5% EBITDA margin, indicating that tariffs, soft auto production, and slower non-auto conversion are weighing more heavily than expected. Consequently, conviction in the base case erodes from 3.5 to 3.0, the attractive entry is trimmed to $70, and the thesis now hinges on a clear H2 re-acceleration toward targeted growth and margin levels.